Working Group on New TB Drugs - Contact Us

Contact Us

Co-Chairs:

Mel Spigelman, MD
Global Alliance for TB Drug Development
40 Wall Street 24th Floor
New York, NY 10005
USA

William Bishai, MD, PhD
Center for Tuberculosis Research
Johns Hopkins University
1550 Orleans St. Room 108
Baltimore, MD 21231-1001

Biology Targets Subgroup Leader:

Christopher Locher, PhD
Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge, MA 02139-4242
USA

Candidates Subgroup Leader:

Barbara Laughon, PhD
Office of the Director Division of Microbiology and Infectious Diseases
National Institute of Allergy & Infectious Diseases (NIH/NIAID)
6610 Rockledge Drive Room 6066
Bethesda, MD 20892-6603
USA

Tools Subgroup Leader:

Gerhard Walzl, PhD
Molecular Biology and Human Genetics,
Faculty of Health Sciences, Stellenbosch University,
PO Box 19063, Tygerberg, 7505
South Africa

Critical Knowledge Subgroup Leader:

Jacques Grosset, MD
Center for TB Research
CRB II, Rm 105
1550 Orleans St,
Baltimore, MD 21231
USA

Clinical Trial Capacity Subgroup Leader:

Christian Lienhardt, MD, PhD
Stop TB Partnership Secretariat
World Health Organization
WHO/STB/TBP
20, Avenue Appia
CH-1211 Geneva 27
Switzerland

Community Representative:

Wim Vandevelde, Chair
European AIDS Treatment Group
Place Raymond Blyckaerts 13
B-1050 Brussels
Belgium

General

Email: StopTBDrugWG@tballiance.org